🎧 Prefer to listen? Play this week's Startupmag Briefing below:
It's Friday, 13 March, and this is your Startupmag Weekly Briefing.
A busy week of UK dealflow saw a mix of large industrial rounds and early-stage raises across HRtech, healthtech and agtech. The period 9–13 Mar 2026 included a £1.5bn AI infrastructure round and multiple health and agriculture financings that pushed the weekly total to £1693.8M.
Startups this week pushed machine learning from proof-of-concept into operational workflows, focusing on generative drafting, behavioural analytics and AI-native deal matching. The emphasis was squarely on practical features that save time and reduce friction, rather than on flashy demos.
Three funding rounds underscored that shift. Avvoka raised £14 million to commercialise its supervised drafting approach and to embed generative AI into legal workflows, with plans for US expansion and further product development. Augur took £11 million in seed funding to deploy sensor and camera networks that provide real-time intelligence for critical infrastructure operators, emphasising behavioural analytics over facial recognition. DealFlowAgent closed a £563k pre-seed to scale an AI-native M&A platform that helps owner-led SMEs prepare for sale and match with suitable acquirers.
Taken together, the deals point to a pragmatic investor appetite for vertical ML solutions — particularly in London — where product-led startups are expected to prove value with pilot customers before scaling more widely.
Avvoka raised £14m in growth funding to commercialise its approach to supervised drafting and embedding generative AI into legal drafting workflows. The capital will support US expansion and product development to help law firms scale consistent, governable drafting processes.
Augur raised £11m in a seed round to deploy software that links cameras and sensors into real‑time intelligence networks for operators of critical infrastructure and public venues. The platform focuses on behavioural analytics rather than facial recognition, aiming to improve detection, response coordination and post‑incident investigation.
DealFlowAgent closed a £563k pre‑seed round to scale an AI‑native M&A platform that helps owner‑led SMEs prepare for sale and match with suitable acquirers. The capital will be used to grow the team and expand the platform’s conversational AI matchmaking and deal execution features.
Funding this week favoured companies moving beyond laboratory proof-of-concept toward production, clinical trials and regulatory readiness. Investors directed capital at scaling manufacturing, advancing pivotal studies and preparing diagnostic AI for the regulatory steps required for commercial use.
Notable rounds included Tropic’s oversubscribed £78.59 million Series C to scale commercial production of gene-edited banana and rice varieties and strengthen supply chains for climate-resilient crops. Cytotrait raised £3 million in seed funding to develop a Mutant Organelle Selection System for chloroplast and mitochondrial edits across key crops. BIOCAPTIVA secured £1.6 million to commercialise magnetic bead technology for liquid biopsy preparation and expand R&D after launching msX kits in the US. Meanwhile, Combat Medical raised £2.6 million to progress HIVEC hyperthermic intravesical chemotherapy trials and support a pivotal FDA registration study.
The pattern is clear: investors are prepared to back both agri-biotech scale-up and clinical validation, signalling demand for companies that can translate scientific advances into regulated, commercial products.
Tropic raised £78.6m to scale commercial production of gene‑edited banana and rice varieties and advance its pipeline of climate‑resilient crops. The oversubscribed Series C will fund global production scale‑up, strengthen supply chains and support commercial partnerships as demand outstrips supply for its first products.
Cytotrait closed a £3m seed round to develop its Mutant Organelle Selection System (MOSS) for introducing traits via chloroplast and mitochondrial edits. The funds will launch programmes in wheat, maize, potato and canola to explore yield, resilience and carbon sequestration traits.
BIOCAPTIVA raised £1.6m to commercialise magnetic bead technology that prepares whole‑blood samples for liquid biopsy. The spin‑out will use the funds to expand R&D and its product range after launching msX kits for research use in the US.
Combat Medical raised £2.6m to advance its HIVEC® hyperthermic intravesical chemotherapy trials for BCG‑unresponsive bladder cancer. The capital will support the pivotal FDA registration trial and further clinical programmes as the company aims to offer a bladder‑sparing alternative to cystectomy.
Investors this week balanced large-scale infrastructure bets with targeted software plays aimed at reducing development cost and schedule risk. The activity ranged from factory-scale capital raises to smaller rounds for specialised components and optimisation tools.
Nscale closed a headline-grabbing £1.5 billion Series C, led by Aker ASA and 8090 Industries alongside strategic investors, to accelerate deployment of renewable-powered AI data centres and vertically integrated AI infrastructure. AmpliSi raised £2 million to commercialise porous silicon anodes for lithium-ion batteries and support scale-up to industrial production for EV and energy-storage applications. Kinewell secured £750k to develop AI software that optimises offshore wind farm cable layouts and turbine placement, using the funds for commercialisation and team growth.
The mix of capital-intensive infrastructure and modestly sized software and materials rounds shows strategic backers are prepared to underwrite both hardware scale-up and the tools that make large projects faster and cheaper to deliver.
Nscale closed a headline-grabbing £1.5bn Series C to accelerate deployment of renewable-powered AI data centres and GPU compute globally. The round, led by Aker ASA and 8090 Industries with a long list of strategic investors, will fund international expansion and build out the company’s vertically integrated AI infrastructure.
AmpliSi secured £2m pre‑seed to commercialise porous silicon anodes for lithium‑ion batteries and support scale‑up from lab to industrial production. The funding will help the team target EV and energy storage applications that need improved energy density and charging performance.
Kinewell raised £750k to develop AI software that optimises offshore wind farm cable layouts and turbine placement to reduce costs and development time. The funds will support commercialisation and job creation as the company doubles its team.
This week’s funding rounds highlighted demand for the plumbing that supports cross-border commerce and niche marketplaces: trading infrastructure, payments, tax compliance and authenticated secondary markets.
QFEX raised £7 million in seed funding to build an exchange for perpetual futures on traditional assets, aiming to offer traders direct market access with lower fees. Outpost closed a £13 million Series A to expand cross-border commerce infrastructure that handles payments, tax and compliance for merchants selling internationally. Hosel secured £500k pre-seed to launch a marketplace for authenticated second-hand golf equipment, using the funds to progress product development and prepare for institutional funding and US expansion.
Together these rounds suggest investors are backing platforms that reduce friction for merchants and traders by simplifying payments and regulatory complexity, while enabling new, scalable marketplaces.
QFEX raised £7m in seed funding to build a trading exchange for perpetual futures on traditional assets. Founded by two Cambridge mathematicians, the startup plans to offer traders direct market access with lower fees and a new product architecture for traditional markets.
Outpost closed a £13m Series A to expand its cross‑border commerce infrastructure that handles payments, tax and compliance for merchants selling internationally. The funding will increase jurisdictional coverage, build product capabilities and scale the team to meet rising demand for local payment rails and tax-of-record services.
Hosel raised £500k pre‑seed to launch a marketplace for authenticated second‑hand golf equipment and improve pricing transparency. The investment will support product development and prepare the company for a planned institutional round and US expansion.
Investors paired growth capital and lending to support operational scale-up, buy-and-build strategies and productivity gains across factories, funds, HR and building safety. The focus was on revenue-backed growth and platforms that integrate with existing corporate workflows.
Isembard secured £37 million in Series A to roll out 25 high-precision component factories and further develop its MasonOS factory operating software across Europe and the US. Preventr obtained a £10 million growth lending facility to support acquisitions and national expansion of its passive fire protection business and AI building-safety analytics. GoodShape received an £8 million facility to refinance debt and accelerate growth of its absence-management and return-to-work platform. ILS raised £2.3 million in seed funding to develop ProVision, a workflow platform that automates side-letter, MFN and post-close fund work.
The week underlines a clear investor preference for solutions that reduce cost and complexity for enterprise customers, with debt often used alongside equity to fund near-term commercial growth.
Isembard secured £37m in Series A to roll out 25 high‑precision component factories and further develop its MasonOS factory operating software. The funding will speed expansion across Europe and the US and support recruitment of engineering and operations teams.
Preventr secured a £10m growth lending facility to support acquisitions and national expansion of its passive fire protection and AI building‑safety analytics. The initial draw funds an acquisition and provides headroom for further buy‑and‑build activity and technology investment.
GoodShape received an £8m facility to refinance debt and accelerate growth of its absence management and return‑to‑work platform. The capital will support customer acquisition and product investment as employers seek better tools to reduce absence and improve workforce productivity.
ILS raised £2.3m in seed funding to develop ProVision, its workflow platform that automates side‑letter, MFN and post‑close fund work for private investment funds. The investment will accelerate product expansion and support the company’s 2026 roadmap.
🎧 That's this week's Startupmag Weekly Briefing.
See you next Friday for another look at the UK startup scene.